Capital expenditure increased 647.1%
Capital expenditure changed +647.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$34,000→$254,0004 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →OBIO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets increased 210.0%
Current assets changed +210.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$35.9M→$111.2M4 prior comparisons
Total assets increased 170.2%
Total assets changed +170.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$42.8M→$115.7M4 prior comparisons
Working capital increased 419.5%
Working capital changed +419.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$18.8M→$97.8M4 prior comparisons
Trade receivables decreased 38.6%
Trade receivables changed -38.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$83,000→$51,0004 prior comparisons
Free-cash-flow proxy decreased 25.9%
Free-cash-flow proxy changed -25.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
-$15.6M→-$19.6M4 prior comparisons
Operating cash flow decreased 24.5%
Operating cash flow changed -24.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
-$15.5M→-$19.3M4 prior comparisons
Current ratio increased 292.6%
Current ratio changed +292.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
2.1→8.264 prior comparisons
Working capital / assets moved 4055 bp higher
Working capital / assets changed +4055 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
43.95%→84.50%4 prior comparisons
Operating margin moved 2309270 bp lower
Operating margin changed -2309270 basis points from the comparable as-filed period.
-2311.84%→-25404.55%3 prior comparisons
Revenue decreased 89.5%
Revenue changed -89.5% from the comparable as-filed period.
$836,000→$88,0003 prior comparisons
Inventory increased 35.1%
Inventory changed +35.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$185,000→$250,0004 prior comparisons
Operating income decreased 15.7%
Operating income changed -15.7% from the comparable as-filed period.
-$19.3M→-$22.4M3 prior comparisons
Research & development increased 19.8%
Research & development changed +19.8% from the comparable as-filed period.
$13.9M→$16.6M3 prior comparisons
Capex / revenue moved 28457 bp higher
Capex / revenue changed +28457 basis points from the comparable as-filed period.
4.07%→288.64%3 prior comparisons
Receivables / revenue moved 4803 bp higher
Receivables / revenue changed +4803 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
9.93%→57.95%3 prior comparisons
Inventory / revenue moved 26196 bp higher
Inventory / revenue changed +26196 basis points from the comparable as-filed period.
22.13%→284.09%3 prior comparisons
SBC / revenue moved 245783 bp higher
SBC / revenue changed +245783 basis points from the comparable as-filed period.
388.76%→2846.59%3 prior comparisons
Stock-based compensation decreased 22.9%
Stock-based compensation changed -22.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.3M→$2.5M4 prior comparisons
Current liabilities decreased 21.0%
Current liabilities changed -21.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$17.1M→$13.5M4 prior comparisons
Cash & equivalents increased 9.2%
Cash & equivalents changed +9.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$18.7M→$20.5M4 prior comparisons
Selling, general & administrative decreased 6.9%
Selling, general & administrative changed -6.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$6.3M→$5.8M3 prior comparisons
Free-cash-flow margin moved 2039545 bp lower
Free-cash-flow margin changed -2039545 basis points from the comparable as-filed period.
-1861.36%→-22256.82%3 prior comparisons
Operating cash-flow margin moved 2011089 bp lower
Operating cash-flow margin changed -2011089 basis points from the comparable as-filed period.
-1857.30%→-21968.18%3 prior comparisons
R&D / revenue moved 1719522 bp higher
R&D / revenue changed +1719522 basis points from the comparable as-filed period.
1657.06%→18852.27%3 prior comparisons
Shares outstanding increased 11.4%
Shares outstanding changed +11.4% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
53,955,085→60,105,0496 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.